Page
Artificial Intelligence and Psoriatic Disease.
Artificial intelligence is transforming psoriasis care by improving diagnosis accuracy, guiding treatment decisions,…
View Report
Page
Holistic Lifestyle Assessment and Psoriasis Susceptibility.
Investigate how maintaining good cardiovascular health, measured by Life’s Essential 8 (LE8), may reduce the risk of…
View Report
Blog
Commentary: Genetic Meta-analysis Identified the Biological Mechanisms of Psoriasis Susceptibility.
Read the latest breakthroughs in psoriasis research with IPC Councilor Dr. Helen Young as she examines a groundbreaking…
Read More
Blog
Exercise and Psoriasis: A Conversation with Dr. Helen Young.
Patients with psoriasis are at increased risk for cardiovascular disease —and lack of physical activity may be a…
Read More
PDF
Biosimilars for the Treatment of Patients with Psoriasis: A Consensus Statement from the Biosimilar Working Group of…
View Report
Page
Biosimilars for Psoriasis—Experience from Europe.
Over the last several years, major changes have occurred in Europe regarding the use of biosimilars. Somecountries such…
View Report
PDF
Clinical Goals and Barriers to Effective Psoriasis Care.
View Report
Page
Biosimilars for Psoriasis: Worldwide Overview of Regulatory Guidelines, Uptake and Implications for Dermatology…
The introduction of biological drugs for the treatment of patients with psoriasis has revolutionized treatment…
View Report
Page
Biosimilars for Psoriasis: Clinical Studies to Determine Similarity.
Biosimilars are drugs that are similar, but not identical, to originator biologics. Preclinical analytical studies are…
View Report
